|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 15-FEB-2023 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 206.8 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 115.9 | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 154.2 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 29.5 L | 40 - 60 | mg/dL |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows elevated total cholesterol and LDL cholesterol, with low HDL cholesterol. This lipid profile indicates increased cardiovascular risk. Consideration should be given to lipid-lowering therapy and lifestyle modifications, in consultation with the treating physician. Regular monitoring is recommended. |